We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Woodcock to Congress: U.S. Must Revamp Manufacturing to Spur APIs
Woodcock to Congress: U.S. Must Revamp Manufacturing to Spur APIs
CDER Director Janet Woodcock called for an overhaul of American drug manufacturing to offset the nation’s dependence on APIs made in China, India and elsewhere, in Oct. 30 remarks to a House subcommittee.